Status:
COMPLETED
Post Traumatic Stress Disorder (PTSD) Hyperarousal Symptoms Treated With Physiological Stress Management
Lead Sponsor:
US Department of Veterans Affairs
Conditions:
Stress Disorders, Post-Traumatic
Eligibility:
All Genders
18-65 years
Phase:
PHASE2
PHASE3
Brief Summary
Hyperarousal is a key symptom of PTSD. Even after receiving trauma-focused therapy, PTSD patients may continue to suffer from hyperarousal. Our main objectives are to measure hyperarousal in VA outpat...
Detailed Description
Hyperarousal is a key symptom of PTSD. Even after receiving trauma-focused therapy, PTSD patients may continue to suffer from hyperarousal. Neuroimaging findings in PTSD support the idea that regulati...
Eligibility Criteria
Inclusion
- \*Participants in the PTSD treatment MUST be US military veterans. Healthy volunteers may include members of the general community, as well as veterans or active duty military personnel\*
- Patients diagnosed by DSM-IV criteria for current PTSD,
- OR met DSM-IV criteria for PTSD within last 5 years.
- Patients must either have participated in a trauma-focused therapy,
- OR have declined to participate in such a therapy.
- In addition, they must currently score positive on at least 2 of the 5 D criteria symptoms.
- This will be defined as having a CAPS frequency plus intensity ratings greater than or equal to 4.
Exclusion
- Patients with evidence of current significant alcohol abuse or dependence, psychosis, or substantial cognitive deficits,
- OR who are severely depressed or acutely suicidal and will not be accepted until these problems are resolved.
Key Trial Info
Start Date :
February 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2013
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT00855816
Start Date
February 1 2010
End Date
July 1 2013
Last Update
October 20 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
VA Palo Alto Health Care System
Palo Alto, California, United States, 94304-1290